Hefei Lifeon Pharmaceutical Co., Ltd. (SHE:003020)
China flag China · Delayed Price · Currency is CNY
15.21
-0.16 (-1.04%)
Nov 6, 2026, 9:35 AM CST

SHE:003020 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
375.77413.89439.69502.93642.58654.25
Short-Term Investments
--10.67---
Trading Asset Securities
230.3440.275861.520.120.13
Cash & Short-Term Investments
606.11454.16508.36564.45642.7654.39
Cash Growth
25.42%-10.66%-9.94%-12.17%-1.79%-14.64%
Accounts Receivable
372.79487.5415.63295.19321.02318.37
Other Receivables
5.014.628.0819.9736.036.08
Receivables
377.8492.12423.7315.16357.05324.45
Inventory
245.11204.5220.48242.91361.76188.86
Prepaid Expenses
-7.261.411.11--
Other Current Assets
38.0218.1931.5427.5191.0351.95
Total Current Assets
1,2671,1761,1851,1511,4531,220
Property, Plant & Equipment
964.54985.66972.75898.62538.12299.03
Long-Term Investments
172.89196.77194.11180.3914.420.71
Goodwill
74.4474.4474.4474.44--
Other Intangible Assets
91.8697.61105.24113.2983.3889.51
Long-Term Deferred Tax Assets
18.5915.8114.5116.138.585.86
Long-Term Deferred Charges
6.493.866.947.417.618.8
Other Long-Term Assets
47.2135.4332.4942.2616.7630.9
Total Assets
2,6432,5862,5862,4842,1211,674

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Accounts Payable
309.14349.46347.53301.25460.66242.93
Accrued Expenses
29.2160.8563.1953.9545.2550.5
Short-Term Debt
19.18505050.05--
Current Portion of Leases
-2.544.364.5410.03-
Current Income Taxes Payable
20.737.479.0815.5312.716.05
Current Unearned Revenue
13.777.5933.0833.0942.6214.69
Other Current Liabilities
92.4842.6874.7184.3251.3613.88
Total Current Liabilities
487.04520.58581.95542.73622.63328.05
Long-Term Debt
108.0759.6459.6531.01--
Long-Term Leases
1.81.714.572.843.3824.58
Long-Term Unearned Revenue
41.9644.918.2820.1612.9813.24
Long-Term Deferred Tax Liabilities
6.287.368.9313.431.39-
Other Long-Term Liabilities
----1.164.66
Total Liabilities
645.15634.19673.38610.18641.53370.53

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Common Stock
228.22190.18191.57159.68122.4792.64
Additional Paid-In Capital
472.01510.05518551.89554.93526.16
Retained Earnings
1,1611,1091,038994.95829.51685.11
Treasury Stock
---9.39-20.99-27.05-
Total Common Equity
1,8611,8091,7381,6861,4801,304
Minority Interest
136.99142.69174.71187.97--
Shareholders' Equity
1,9981,9521,9131,8731,4801,304
Total Liabilities & Equity
2,6432,5862,5862,4842,1211,674

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Total Debt
131.59113.9118.5888.4413.4124.58
Net Cash (Debt)
474.52340.27389.78476629.28629.8
Net Cash Growth
13.78%-12.70%-18.11%-24.36%-0.08%-17.84%
Net Cash Per Share
2.061.491.702.062.782.79
Filing Date Shares Outstanding
228.19228.22229.51229.93229.26225.45
Total Common Shares Outstanding
228.19228.22229.89229.93229.26225.45
Working Capital
779.99655.66603.54608.42829.92891.59
Book Value Per Share
8.167.937.567.336.465.78
Tangible Book Value
1,6951,6371,5581,4981,3961,214
Tangible Book Value Per Share
7.437.176.786.516.095.39
Buildings
-753.46547.66395.67140.12127.89
Machinery
-562.23480.99303.79174.84139.8
Construction In Progress
-51.66269.34459.66340.89130.35